In hepatocellular carcinoma, CHEK1 activates CDC25C through phosphorylation, relieving CDK1 inhibition and promoting the G2/M phase transition, thus accelerating proliferation. This evidence concerns the gene CDK1 and hepatocellular carcinoma.